Catalyst Wire Dossier Catalyst Wire Dossier

INFLECTRA

infliximab-dyyb · Pfizer Laboratories Div Pfizer Inc
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for INFLECTRA, covering 2015-05-22 to 2026-07-28. Get the full timeline:

Most recent: EMA Withdrawn: Inflectra (infliximab) — Pfizer Europe MA EEIG

See pricing